Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126492661 | 12649266 | 1 | I | 20160303 | 20160511 | 20160812 | 20160812 | EXP | US-TEVA-660725USA | TEVA | 51.06 | YR | F | Y | 0.00000 | 20160812 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126492661 | 12649266 | 1 | PS | CLOZAPINE. | CLOZAPINE | 1 | Oral | U | 74949 | 450 | MG | TABLET | |||||||
| 126492661 | 12649266 | 2 | SS | SEROQUEL | QUETIAPINE FUMARATE | 1 | 200 MILLIGRAM DAILY; | U | 0 | 200 | MG | QD | |||||||
| 126492661 | 12649266 | 3 | SS | DEPAKOTE | DIVALPROEX SODIUM | 1 | 1750 MILLIGRAM DAILY; | U | 0 | 1750 | MG | QD | |||||||
| 126492661 | 12649266 | 4 | C | ARTHAXAN | 2 | 4 MILLIGRAM DAILY; | 0 | 4 | MG | QD |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126492661 | 12649266 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126492661 | 12649266 | Cervical vertebral fracture | |
| 126492661 | 12649266 | Craniocerebral injury | |
| 126492661 | 12649266 | Fall | |
| 126492661 | 12649266 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |